On February 27th ET, $Viking Therapeutics (VKTX.US)$ had active options trading, with a total trading volume of 80,554 options for the day, of which put options accounted for 58.63% of the total transactions, and call options accounted for 41.37%.
It shows that as of the close of the day, the open interest of $Viking Therapeutics (VKTX.US)$, indicating options positions have not been closed, totaled about 104.72K contracts, which was 124.2% of the average of the past 30 trading days.
When $Viking Therapeutics (VKTX.US)$ was trading at $76.10, the call option with $55.00 of strike price expiring on April 19th,2024 transacted 4,000 contracts. It ranked first among $Viking Therapeutics (VKTX.US)$ unusual option trades of the day and reflected $10.42 million turnover.
Additionally, in terms of the total trading volume for the day, the most active option contract of $Viking Therapeutics (VKTX.US)$ achieved 12,561 volume and closed at $0.20.
See below for more details:
Notes:
Select the top 70 stocks based on options volume on trading day.
The article will be published after the options trading hours.
Volume/30-Day Average Volume (OR Total Volume DoD) and OI/30-Day Average OI (OR OI DoD) reflect the changes in overall options activities compared to the past.
The chart shows the cumulative distribution of open interest of all expiration dates per different strike prices. 10 strike prices that are closest to the current underlying price are presented. The chart conveys the market views of the future underlying price.
Options trades with a size of more than 1,000 contracts will be marked as unusual trades.
Options trading entails significant risk and is not appropriate for all customers. It is important that investors read Characteristics and Risks of Standardized Options before engaging in any options trading strategies. Options transactions are often complex and may involve the potential of losing the entire investment in a relatively short period of time. Certain complex options strategies carry additional risk, including the potential for losses that may exceed the original investment amount. Supporting documentation for any claims, if applicable, will be furnished upon request.
The past performance of a security or financial product does not guarantee future results or returns. Customers should consider their investment objectives and risks carefully before investing in options. Because of the importance of tax considerations to all options transactions, the customer considering options should consult their tax advisor as to how taxes affect the outcome of each options strategy.
美东时间2月27日，$Viking Therapeutics (VKTX.US)$期权成交活跃，当日期权总成交量达8.06万张，其中看跌期权占总成交量的58.63%，看涨期权占41.37%。
数据显示，截至当日收盘，$Viking Therapeutics (VKTX.US)$未平仓合约（即没有买卖或行权的期权合约）总计约10.47万张，与其近30交易日均值比为124.2%。
值得注意的是，在$Viking Therapeutics (VKTX.US)$成交价格为76.10美元时，出现一笔看涨期权的异动大单，其以4,000张的成交量荣登大单榜首，涉资1,042万美元。该期权的行权价为55.00美元，到期日为2024年4月19日。
另外，从全日成交量来看，$Viking Therapeutics (VKTX.US)$当日最活跃的期权合约总计成交1.26万张，收盘价0.20美元。
详情请见下文图表：
提示：
选取全市场当天期权成交量排序的前70只个股。
于交易日美东时间期权交易结束后生成。
总成交量/近30交易日均值（或成交量环比）、未平仓合约/近30交易日均值（或未平仓合约环比），这些指标反映个股期权整体活跃较以往的变化。
未平仓合约分布图显示了不同行权价下所有到期日未平仓权益的累积分布。图中列出了与当前标的收盘价格最接近的10个行权价。图片一定程度上反映了市场对标的未来潜在价格的看法。
成交量大于1000张的期权交易将被标记为异动大单。
异动大单、期权合约成交榜均以成交量排序。
期权交易特点及风险
交易期权前，投资者应了解其交易特点和风险，详情请参考Options Disclosure Document(ODD)。
